Apollo Hospitals Jumps ~4.6% to 52-Week High on AI & Q2 FY27
APOLLOHOSP Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is rallying sharply in morning trade on Friday, November 20, 2026, standing out among Nifty 50 gainers even as broader benchmarks face pressure from a global tech selloff. Market Snapshot (As of ~10:30 AM IST, Nov 20, 2026) Trading Price: Around ₹9,137 – ₹9,141 on the NSE (up roughly 4.6% from the previous close of ₹8,738). Intraday Range & 52-Week High: Opened at ₹8,820, hit a low of ₹8,800, and touched a fresh 52-week high of ₹9,205 earlier in the morning session. Healthcare Sector Momentum: Hospital and healthcare stocks are attracting defensive and domestic buying today, helping lift the Nifty Healthcare Index alongside peers like Max Healthcare. Recent Company Developments AI in Patient Safety (Nov 17, 2026): Featured in a Microsoft report detailing how Apollo clinicians use a continuous-learning AI agent to speed up case closures and proactively track patient safety metrics such as falls and medication errors. Clinical & Facility Updates (Mid-November 2026): Recent announcements across the network include a combined TAVI and BMV structural heart procedure in Hyderabad, a smart endourology operating room in Bhubaneswar, a cath lab upgrade in Guwahati, and recognition for Dr. P. Vijay Anand Reddy at Best of ASCO India 2026. Q2 FY27 Earnings & Leadership (Early November 2026): For the quarter ended September 30, 2026, Apollo reported strong year-on-year growth—with consolidated revenue up ~23% to ₹7,615 crore and net profit rising ~32% to ₹630 crore—alongside senior leadership transitions (including Dr. Madhu Sasidhar stepping down as President & CEO of the Hospitals Division on November 14, 2026, and regional/international leadership appointments).




















